XBIOTECH INC. Increase (Decrease) in Accrued Interest Receivable, Net
XBIOTECH INC. (XBIT) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$83.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2026-08-13
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-06-30 was -$25.00K.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-03-31 was -$58.00K.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-12-31 was -$90.00K.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-09-30 was -$30.00K.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for fiscal 2025 was -$340.00K.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for fiscal 2024 was -$160.00K.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for fiscal 2023 was -$356.00K, a 129.28% decline from fiscal 2022.
- XBIOTECH INC. increase (decrease) in accrued interest receivable, net for fiscal 2022 was $1.22M.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$83.00K 10-Q · filed 2026-08-13 | -$173.00K derived: sum of 3 quarters · filed 2026-08-13 | -$203.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$58.00K 10-Q · filed 2026-05-14 | -$148.00K derived: sum of 2 quarters · filed 2026-05-14 | -$178.00K derived: sum of 3 quarters · filed 2026-05-14 | -$178.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$120.00K derived: sum of 2 quarters · filed 2026-03-13 | -$120.00K derived: sum of 3 quarters · filed 2026-08-13 | -$340.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$30.00K derived: sum of 2 quarters · filed 2026-08-13 | -$250.00K 10-Q · filed 2025-11-12 | -$280.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$220.00K 10-Q · filed 2026-08-13 | -$250.00K derived: sum of 3 quarters · filed 2026-08-13 | -$390.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$220.00K 10-Q · filed 2026-05-14 | -$250.00K derived: sum of 2 quarters · filed 2026-05-14 | -$390.00K derived: sum of 3 quarters · filed 2026-05-14 | -$390.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$170.00K derived: sum of 2 quarters · filed 2026-03-13 | -$170.00K derived: sum of 3 quarters · filed 2026-03-13 | -$160.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | -$140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$140.00K derived: sum of 2 quarters · filed 2025-11-12 | -$130.00K 10-Q · filed 2025-11-12 | -$151.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $10.00K 10-Q · filed 2025-08-13 | -$11.00K derived: sum of 3 quarters · filed 2025-08-13 | -$2.35M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $10.00K 10-Q · filed 2025-05-14 | -$11.00K derived: sum of 2 quarters · filed 2025-05-14 | -$2.35M derived: sum of 3 quarters · filed 2025-05-14 | -$1.50M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.36M derived: sum of 2 quarters · filed 2025-03-18 | -$1.51M derived: sum of 3 quarters · filed 2025-03-18 | -$356.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.49M derived: sum of 2 quarters · filed 2024-11-13 | -$335.00K 10-Q · filed 2024-11-13 | $881.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $846.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $2.00M 10-Q · filed 2024-08-12 | $3.22M derived: sum of 3 quarters · filed 2024-08-12 | $3.22M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.16M 10-Q · filed 2024-05-10 | $2.37M derived: sum of 2 quarters · filed 2024-05-10 | $2.37M derived: sum of 3 quarters · filed 2024-05-10 | $2.37M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.22M derived: sum of 2 quarters · filed 2024-03-15 | $1.22M derived: sum of 3 quarters · filed 2024-03-15 | $1.22M 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |